Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida.
JAMA Oncol. 2022 May 1;8(5):748-754. doi: 10.1001/jamaoncol.2022.0001.
JAMA Oncol. 2022.
PMID: 35266953
Free PMC article.
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021.
Giuliano AR, Pilon-Thomas S, Schell MJ, Abrahamsen M, Islam JY, Isaacs-Soriano K, Kennedy K, Dukes CW, Whiting J, Rathwell J, Hensel JA, Mangual LN, Schonbrunn E, Bikowitz M, Grassie D, Yang Y.
Giuliano AR, et al. Among authors: dukes cw.
Emerg Infect Dis. 2022 Mar;28(3):556-563. doi: 10.3201/eid2803.211495. Epub 2022 Jan 26.
Emerg Infect Dis. 2022.
PMID: 35081021
Free PMC article.
Item in Clipboard
SARS-CoV-2 antibody response duration and neutralization following natural infection.
Dukes CW, Rossetti RA, Hensel JA, Snedal S, Cubitt CL, Schell MJ, Abrahamsen M, Isaacs-Soriano K, Kennedy K, Mangual LN, Whiting J, Martinez-Brockhus V, Islam JY, Rathwell J, Beatty M, Hall AM, Abate-Daga D, Giuliano AR, Pilon-Thomas S.
Dukes CW, et al.
J Clin Virol Plus. 2023 Aug;3(3):100158. doi: 10.1016/j.jcvp.2023.100158. Epub 2023 Jul 1.
J Clin Virol Plus. 2023.
PMID: 37654784
Free PMC article.
Item in Clipboard
Long-Term CD4+ T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study.
Gallen C, Dukes CW, Aldrich A, Macaisa L, Mo Q, Cubitt CL, Pilon-Thomas S, Giuliano AR, Czerniecki BJ, Costa RLB.
Gallen C, et al. Among authors: dukes cw.
Vaccines (Basel). 2022 Nov 15;10(11):1931. doi: 10.3390/vaccines10111931.
Vaccines (Basel). 2022.
PMID: 36423026
Free PMC article.
Item in Clipboard
First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0.
Markowitz J, Shamblott M, Brohl AS, Sarnaik AA, Eroglu Z, Khushalani NI, Dukes CW, Chamizo A, Bastawrous M, Garcia ET, Delhawi A, Chen PL, De Aquino DB, Sondak VK, Tarhini AA, Kim Y, Lawman P, Pilon-Thomas S.
Markowitz J, et al. Among authors: dukes cw.
Mol Cancer Ther. 2024 Apr 24. doi: 10.1158/1535-7163.MCT-23-0652. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38657233
Item in Clipboard
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.
Dukes CW, Potez M, Lancet J, Kuter BJ, Whiting J, Mo Q, Leav B, Wang H, Vanas JS, Cubitt CL, Isaacs-Soriano K, Kennedy K, Rathwell J, Diaz Cobo J, O'Nan W, Sirak B, Dong N, Tan E, Hwu P, Giuliano AR, Pilon-Thomas S.
Dukes CW, et al.
Vaccines (Basel). 2023 Dec 22;12(1):13. doi: 10.3390/vaccines12010013.
Vaccines (Basel). 2023.
PMID: 38250826
Free PMC article.
Item in Clipboard
Cite
Cite